Here - EWMA 2013

ORAL PRESENTATIONS
5
Opening Session: Multidisciplinarity and Organisation of Care
Examples of multidisciplinary collaboration from cancer and
palliative care
Mogens Grønvold 1
1 Department of Public Health, Faculty of Health and Medical Sciences, Copenhagen
University (Copenhagen, Denmark)
Multidisciplinary collaboration plays an important role in cancer and palliative care.
This presentation reports on the experiences in Denmark at three levels:
1. Based on succesful experiences in breast and lung cancer, diagnosis specific
multidiciplinary groups were established covering the whole cancer area, and this
facilitated national implementation of 'packages' leading to faster diagnosis and start
of treatment.
2. Using the same model for palliative care, a truly multiprofessional organisation was
established leading to development of multidisciplinary clinical guidelines, education
programs, and research collaboration.
3. Within the same organisation, a national database was established measuring
several quality indicators including the proportion of patients discussed at
multidisciplinary conferences. Thus, within the cancer field multidisciplinary
organisations and collaboration have been succesful elements in quality
improvement.
KEY SESSION: REGENERATIVE MEDICINE
6
Key Session: Regenerative Medicine
Mechanism of inhibition of wound healing challenging patients
outcome
Marjana Tomic-Canic 1
1 University of Miami, Miller School of Medicine (Coral Gables, Miami, United States)
Chronic wounds, diabetic foot ulcers, venous ulcers and pressure ulcers, represent a
clinical challenge with high morbidity, mortality, and cost. The development of new
treatment approaches is essential and is limited by the current understanding of
molecular mechanisms that inhibit wound healing. Furthermore, a better understanding
is needed to foresee which wounds will respond to standard care and which require
more aggressive interventions. A summary of new knowledge regarding inhibition of
wound healing in patients will be presented as well as utilization of this knowledge to
develop feasible, quantifiable, tissue specific biomarkers that can predict healing
outcomes in patients. Furthermore, new treatment approaches including allogeneic and
autologous progenitor cells will be discussed.
22